Peptide Protocols for Anti-Aging: A Complete Stack Guide

Aging isn't a single event. It's a slow-motion cascade of biological failures — each one relatively subtle on its own, each one compounding the next. Collagen production starts declining in your late twenties. Growth hormone secretion drops by roughly 15% per decade after thirty. Mitochondrial efficiency drifts. Chronic low-grade inflammation — what researchers call "inflammaging" — builds over years without obvious symptoms until it's driving every major degenerative process in the body.

By the time most people notice they're aging, the underlying biology has been sliding for a decade.

This is where peptides enter the conversation differently than most anti-aging compounds. Peptides aren't overriding or replacing biological systems — they're signaling molecules, the same language your body already speaks. GHK-Cu doesn't manufacture collagen; it upregulates your cells' own collagen synthesis pathways. Epithalon doesn't slow time; it modulates the pineal-telomere axis that governs cellular longevity. Ipamorelin doesn't flood your system with exogenous growth hormone; it restores the pulsatile GH secretion your pituitary already runs but runs less frequently with each passing year.

Think of the best peptides for anti-aging less as drugs and more as restoration tools — interventions designed to bring your own systems back toward their earlier operating levels. That framing matters for how you approach protocols, expectations, and timelines.

This guide covers six of the most studied and widely used anti-aging peptides, how to stack them by experience level, and what to realistically expect across a 3–6 month timeline.

The Core Mechanisms of Aging (and Where Peptides Intervene)

Before you can build an intelligent anti-aging peptide protocol, you need a clear model of what you're actually targeting. Four mechanisms account for the majority of the age-related decline most people are trying to address:

Collagen loss and structural degradation. Collagen is the most abundant protein in the human body — the structural foundation of skin, tendons, ligaments, cartilage, bone, and blood vessels. Fibroblast activity (the cells that synthesize collagen) begins declining around age 25–30, and it accelerates with sun exposure, chronic stress, poor sleep, and metabolic dysfunction. The skin changes are the most visible output, but the connective tissue degradation throughout the rest of the body — joint health, gut lining integrity, cardiovascular flexibility — is arguably more important.

Growth hormone axis decline. The pituitary's GH output peaks in adolescence and declines steadily from age 30 onward. GH drives cellular repair, fat mobilization, muscle protein synthesis, and immune function. Its downstream messenger IGF-1 governs tissue growth and regeneration. When both drop, the downstream consequences are broad: slower healing, more fat accumulation (particularly visceral), reduced lean mass, lower energy, and worse recovery from any stressor.

Mitochondrial drift and cellular energy failure. Mitochondria — the organelles that generate ATP — become progressively less efficient with age. Mitochondrial DNA accumulates damage, the electron transport chain produces more reactive oxygen species (ROS), and cellular energy output declines. This is why fatigue, cognitive fog, and reduced physical performance are so consistent across aging populations. Cells that can't produce energy efficiently can't repair themselves.

Inflammaging — chronic low-grade inflammation. This is perhaps the most underappreciated mechanism. Unlike acute inflammation (which heals injuries and resolves), inflammaging is persistent, systemic, and subclinical — you can't feel it, but it's measurable in IL-6, TNF-alpha, and CRP blood markers. It's strongly associated with every major age-related disease: cardiovascular disease, dementia, cancer, metabolic syndrome, and accelerated tissue degradation. Gut dysbiosis, visceral fat, accumulated cellular debris, and chronic stress all feed it.

The peptides in this guide each target one or more of these mechanisms. The stack approach is about covering multiple mechanisms simultaneously — because aging isn't happening in only one place.

The Six Peptides for Anti-Aging

1. GHK-Cu (Copper Tripeptide)

GHK-Cu (glycyl-L-histidyl-L-lysine complexed with copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine — with plasma concentrations that decline dramatically from roughly 200 ng/mL at age 20 to around 80 ng/mL by 60. That decline tracks closely with the skin aging, wound healing slowdown, and connective tissue degradation most people associate with middle age.

GHK-Cu's mechanisms are remarkably broad for a three-amino-acid peptide. It upregulates collagen, elastin, and glycosaminoglycan synthesis in fibroblasts; promotes angiogenesis (formation of new blood vessels) in wound healing; activates metalloproteinases to break down and remodel damaged collagen into fresh matrix; and demonstrates neuroprotective effects through antioxidant gene expression activation. Research published by Loren Pickart and colleagues has catalogued over 4,000 gene expression changes associated with GHK-Cu — many of them related to restoring gene activity patterns characteristic of younger tissue.

The practical applications are extensive: topical application improves skin texture, reduces fine lines, and supports hair growth (it's a common active ingredient in high-end cosmetic serums). Injectable GHK-Cu, while less commonly discussed, is used by longevity practitioners for systemic collagen support and wound healing acceleration beyond what topical can achieve.

For someone new to anti-aging peptides, topical GHK-Cu is the lowest-barrier starting point — meaningfully effective for skin and hair, no injection required, and well-tolerated. For deeper systemic effects on connective tissue and collagen throughout the body, injectable protocols are available. Full breakdown at /learn/ghk-cu-anti-aging-peptide.

Typical use: Topical serums applied morning and/or evening; injectable protocols typically 1–3 mg per injection, several times weekly.

2. Epithalon (Epitalon)

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a natural extract of the pineal gland. It has arguably the strongest research foundation of any longevity peptide currently in use — studied extensively by the St. Petersburg Institute of Bioregulation and Gerontology across both animal models and human trials beginning in the 1980s.

Epithalon's core mechanism involves activation of telomerase — the enzyme responsible for maintaining telomere length. Telomeres are the protective caps on chromosomes; they shorten with each cell division, and when they become critically short, cells stop dividing (senescence) or die. Telomere shortening is one of the most reliable molecular clocks of biological aging. Research has shown Epithalon can lengthen telomeres in human cells, with the most compelling data coming from studies in aging populations where subjects showed improved biological aging markers after Epithalon treatment cycles.

Beyond telomerase, Epithalon directly modulates pineal gland function — normalizing melatonin secretion patterns, which regulates the entire circadian-hormonal cascade and has downstream effects on sleep quality, GH secretion, and immune function. This circadian regulation aspect makes Epithalon particularly relevant for people whose sleep architecture has deteriorated with age.

Critically: Epithalon is a cycle-only compound. The research protocol and standard clinical practice both model it as a defined short course — typically 10 consecutive days at 5–10 mg/day — administered once or twice per year. This isn't a daily compound. The biological mechanisms it targets (telomerase activation, pineal modulation) don't benefit from continuous administration the way some GH secretagogues might in extended protocols, and the research doesn't support continuous use.

Typical protocol: 5–10 mg/day subcutaneous or intranasal for 10 consecutive days, 1–2 cycles per year.

3. BPC-157

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice, and it's one of the most versatile peptides in the research literature — with a particular relevance to anti-aging through its effect on the inflammatory pathways that drive biological aging.

The core mechanism most people focus on is tissue repair: BPC-157 promotes angiogenesis, accelerates tendon and ligament healing, upregulates growth factor signaling in injured tissue, and protects against gut mucosal damage. For longevity purposes, though, the more important mechanism is systemic anti-inflammatory activity. BPC-157 significantly reduces levels of pro-inflammatory cytokines and modulates the nitric oxide system — which governs vascular health, blood pressure, and endothelial function. Chronic systemic inflammation is one of the primary accelerators of biological aging; anything that meaningfully reduces it is operating at a root-cause level rather than downstream symptoms.

The gut-brain axis connection adds another dimension. BPC-157 has robust evidence for gut health and intestinal integrity, and the gut microbiome has increasingly well-documented effects on systemic inflammation, cognitive function, and even metabolic rate. Restoring gut lining integrity through BPC-157 may reduce the low-grade endotoxemia (gut-derived immune activation) that drives a significant portion of age-related inflammaging in metabolically compromised individuals.

For anti-aging specifically: think of BPC-157 as the compound that addresses the inflammatory substrate that makes aging go faster. It's not glamorous telomere science, but chronic inflammation is one of the most modifiable aging mechanisms, and BPC-157 is one of the more direct tools for addressing it.

Typical dosing: 250–500 mcg once or twice daily, subcutaneous or oral. Morning dosing is common; some practitioners split morning/evening for systemic anti-inflammatory effect.

4. Ipamorelin / CJC-1295

Ipamorelin and CJC-1295 (no DAC) are almost always discussed and used together because they work through complementary mechanisms on the same axis — and the combination produces a synergistic GH pulse substantially larger than either compound achieves alone.

The GH decline story is central to the anti-aging case for this pair. GH secretion peaks in adolescence and declines roughly 14–15% per decade after age 30. By the time most people are in their mid-forties, they're producing a fraction of the GH they had in their twenties — with downstream effects on lean mass, fat distribution, recovery capacity, skin collagen, bone density, and sleep quality. This isn't a disease state; it's a predictable age-related change. But it's a change with measurable consequences.

Ipamorelin is a GHRP (GH-releasing peptide) — it mimics ghrelin to trigger a GH pulse from the pituitary, cleanly and selectively, without the cortisol or prolactin spikes that made older GHRPs problematic. CJC-1295 (no DAC) is a GHRH analog — it acts at the GHRH receptor to amplify and sustain the pulse Ipamorelin initiates. Together, they restore a pattern of pulsatile GH secretion that closely mirrors what your pituitary was doing naturally at an earlier age — rather than flooding the system with a continuous flat level of exogenous GH.

That pulsatility distinction matters. Natural GH works in sharp pulses — the sharp rise triggers the downstream IGF-1 cascade in muscle and connective tissue, then the quick fall allows receptor sensitivity to reset. Exogenous GH at supraphysiological doses breaks that rhythm and can suppress natural production. Ipamorelin/CJC-1295, by contrast, preserve natural feedback mechanisms while amplifying output — a fundamentally different and more sustainable approach.

For an in-depth comparison of how these two peptides differ and how to structure the combination, see /learn/ipamorelin-vs-cjc-1295.

Typical dosing: Ipamorelin 200–300 mcg + CJC-1295 (no DAC) 100–200 mcg, subcutaneous, 30–45 minutes before bed in a fasted state.

5. Thymosin Alpha-1 (TA-1)

Thymosin Alpha-1 is a naturally occurring peptide produced by the thymus gland — the primary organ of immune system education and maturation. The thymus is also one of the first organs to undergo significant age-related involution: it begins shrinking after puberty, and by middle age, most of its functional tissue has been replaced by fat. The decline in thymic function is a core driver of immune aging (immunosenescence) — the gradual deterioration of immune competence that makes older adults more susceptible to infection, less responsive to vaccines, and more prone to the chronic immune activation that feeds inflammaging.

TA-1 restores thymic signaling and enhances T-cell maturation, proliferation, and function. In clinical settings, it has been used for years in immune-compromised patients and as an adjunct therapy in viral infections and certain cancers. Its application in longevity medicine is newer but follows the same logic: immune decline is a measurable mechanism of aging, not just a downstream consequence of it. Addressing thymic function directly — rather than waiting for infectious disease to manifest — is legitimate upstream intervention.

TA-1 is increasingly popular in longevity clinics alongside other anti-aging peptides, often combined with BPC-157 for its anti-inflammatory synergy. It's the compound on this list most likely to have a practitioner involved in the protocol — both because the immune implications of modulating T-cell activity are more nuanced than GH or collagen work, and because the use cases and dosing schedules benefit from clinical oversight.

Typical dosing: 1.5 mg subcutaneous, 2–3 times per week. Often cycled in 1–3 month courses. Commonly used in longevity clinic settings.

6. Selank

Selank is a synthetic analog of the endogenous peptide tuftsin, developed at the Institute of Molecular Genetics in Moscow. It's primarily known as an anxiolytic and nootropic — it reduces anxiety and improves cognitive function without the sedation or dependence associated with benzodiazepines. But its relevance to anti-aging protocols is through what it does to cortisol.

Cortisol management is one of the most underrated levers in any serious longevity program. Cortisol is your primary stress hormone — essential in short bursts, profoundly destructive when chronically elevated. Chronic high cortisol breaks down muscle protein, accelerates visceral fat accumulation, degrades skin collagen, suppresses GH and testosterone production, impairs sleep architecture, drives immune dysfunction, and promotes neuroinflammation. It is, by most of the evidence, one of the most potent accelerators of biological aging across multiple systems simultaneously.

Selank blunts the chronic stress response through GABA-modulatory effects and modulation of brain-derived neurotrophic factor (BDNF) — which supports neuronal survival and plasticity. Users commonly report significantly reduced baseline anxiety, sharper cognitive clarity, and improved stress resilience within days of starting. For someone whose aging acceleration is being driven significantly by chronic psychological stress — as is the case for most high-performing adults — addressing the cortisol load directly may be as important as any other intervention in the stack.

Selank can be administered subcutaneously or intranasally; intranasal is the more common route given its rapid onset for cognitive and anxiolytic effects.

Typical dosing: 250–500 mcg intranasally or subcutaneously, 1–2 times per day. Can be used as-needed (acute stress) or in structured cycles.

The Anti-Aging Peptide Stacks

Beginner Stack: GHK-Cu + Ipamorelin/CJC-1295

This is the entry point — chosen because both are well-characterized, the risk profiles are understood, and together they address two of the most measurable aging mechanisms: collagen decline and GH axis decline.

• GHK-Cu (topical): Applied morning and/or evening to face, neck, and any area of primary concern. No injection required. Expect gradual improvements in skin texture, hydration, and fine lines across 6–12 weeks of consistent use.
• Ipamorelin 200–300 mcg + CJC-1295 100–200 mcg (no DAC): Subcutaneous injection 30–45 minutes before bed, fasted. This nighttime GH stack amplifies your natural sleep-time GH pulse for better overnight repair, body composition support, and sleep quality.

Why these two for a beginner? GHK-Cu has no injection requirement and immediate accessibility; Ipamorelin/CJC-1295 produces the most consistent and broadly beneficial effect in the GH category with a clean safety profile and no suppression of natural feedback. The combination covers two major mechanisms without overwhelming complexity. Run 8–12 weeks, take 4 weeks off, and assess results before adding anything.

Intermediate Stack: Add Epithalon + BPC-157

Once you've established the beginner stack and understand your individual response, the intermediate level adds the other two most impactful compounds for longevity:

• Epithalon (10-day cycle): 5–10 mg/day for 10 consecutive days, subcutaneous or intranasal, 1–2 times per year. This is a periodic telomere and circadian reset tool — schedule it at the beginning of a peptide cycle rather than running it alongside everything simultaneously at first.
• BPC-157 250–500 mcg/day: Daily subcutaneous injection targeting systemic inflammation, gut integrity, and tissue repair. Many practitioners recommend running BPC-157 continuously or in extended 12-week cycles due to its anti-inflammatory effects.

The intermediate stack now covers four mechanisms: collagen synthesis (GHK-Cu), GH restoration (Ipamorelin/CJC-1295), telomere/circadian biology (Epithalon), and inflammaging (BPC-157). For most people in the 35–55 age range, this four-compound approach represents a comprehensive anti-aging protocol.

Advanced / Longevity Clinic Stack: Add TA-1 + Selank

The advanced stack adds immune restoration and cortisol management — the two mechanisms most likely to require practitioner involvement and the two that are most individually variable in their application.

• Thymosin Alpha-1 1.5 mg: 2–3 times per week subcutaneous. Typically run in 1–3 month cycles. Addresses immune aging and T-cell function — a core but often overlooked mechanism of biological aging.
• Selank 250–500 mcg: Intranasal or subcutaneous, 1–2 times daily. Manages the chronic cortisol load that undermines every other anti-aging intervention in the stack.

This level of protocol — running five to six compounds across multiple mechanisms — is where practitioner oversight becomes genuinely valuable, not just precautionary. The interactions are manageable, but optimizing the complete protocol requires understanding your individual biomarkers (IGF-1, inflammatory markers, thyroid, cortisol, sex hormones) and adjusting accordingly. Most serious longevity clinics run something close to this stack for their patients.

Build your complete protocol with confidence. The Peptide Stacking Guide: Advanced Protocols covers complete anti-aging stack protocols, cycling schedules, and dosing specifics in one place. Get the Stacking Guide — $14.99 →

Key Protocol Principles

Cycling is non-negotiable — especially for Epithalon.

Epithalon is a 10-day course, not a daily supplement. The telomerase and pineal effects are achieved through the structured short cycle; continuous use isn't supported by the research and isn't how the compound works. Ipamorelin/CJC-1295 should be cycled 8–12 weeks on, 4–6 weeks off to preserve receptor sensitivity. Even BPC-157 benefits from defined cycles in most protocols, though some practitioners run it longer-term for its anti-inflammatory effects. Build your calendar around defined courses, not indefinite ongoing use.

Timing matters for GH secretagogues.

Ipamorelin and CJC-1295 must be dosed fasted — no food for at least 2–3 hours before injection. Elevated insulin from a recent meal suppresses GH release, which directly undermines the entire point of these peptides. Bedtime dosing in a fasted state is the standard protocol because it aligns the pharmaceutical GH pulse with the natural sleep-time GH peak, amplifying what your body was already going to do. Deviating from this timing — dosing with food, or at non-fasted times — significantly reduces effectiveness.

Anti-aging timelines are measured in months, not weeks.

This is where most people's expectations need calibration. The mechanisms you're targeting — collagen remodeling, GH axis restoration, telomere maintenance, immune reconstitution — operate on biological timescales. Skin changes take 8–12 weeks of consistent GHK-Cu use to become clearly visible. GH-related body composition shifts take a full 8–12 week cycle before they're meaningfully apparent. Bloodwork changes in IGF-1 and inflammatory markers show most clearly at the 3-month mark. Patience isn't optional in anti-aging work — it's built into the biology.

What to Realistically Expect

Anti-aging is one of the areas where marketing overclaims and reality diverge most dramatically. Here's an honest breakdown of what you can actually feel vs. what shows up in objective markers over 3–6 months of a well-structured protocol.

What you'll likely feel:

• Weeks 2–4: Improved sleep quality (more vivid dreams, more restorative mornings) from the Ipamorelin/CJC-1295 stack. Reduced baseline anxiety and better stress management from Selank if included. These are the earliest subjective changes and the most consistent across users.
• Weeks 4–8: Noticeably improved recovery between training sessions. Reduced joint aches and soreness — especially from BPC-157's anti-inflammatory effect. Some users report improved cognitive clarity in this window.
• Months 2–3: Visible skin texture improvements, especially with consistent topical GHK-Cu. Body composition shifts beginning to show (more definition, reduced midsection fat). Energy and motivation trending upward as the GH axis stabilizes.

What shows in bloodwork and objective markers:

• IGF-1: Should trend upward across a full GH secretagogue cycle, reflecting improved GH output. Typical increase depends heavily on baseline, but a meaningful rise from your pre-protocol level is the target signal.
• Inflammatory markers (CRP, IL-6): Should trend down, particularly with BPC-157 and TA-1 in the protocol. This is one of the most important anti-aging markers to track — chronic inflammation predicts long-term outcomes better than almost any other blood test.
• Skin and connective tissue: Improved dermal density and elasticity are measurable via skin ultrasound or high-resolution photography at 90-day intervals. GHK-Cu effects on collagen density are documentable even when they're not obvious to casual observation.
• Telomere length: The most meaningful but least practical marker. Telomere length testing exists and Epithalon has evidence for positive effects, but the measurement variability and cost mean most people don't track this practically. Treat Epithalon as a long-game investment you can trust the research on rather than something you'll measure directly.

For a deeper look at peptides and longevity biomarkers, see /learn/nad-plus-peptides-longevity.

Frequently Asked Questions

When is it too late to start?

There's genuinely no hard cutoff. The research on Epithalon includes elderly populations in their 70s and 80s and shows measurable benefits. GHK-Cu's collagen effects are relevant at any age where fibroblast activity is declining — which starts in your late twenties and continues. GH secretagogues produce the most dramatic response in people with meaningful GH decline, which actually increases with age. The honest answer is that the benefits are in many ways more pronounced at 55 than at 35, because the baseline deficit is larger. Starting earlier is better, but starting later is far better than not starting. The biology doesn't have an expiration date.

Can women use anti-aging peptides?

Yes — all six peptides discussed in this guide are used by women in longevity and anti-aging contexts, and several of them have particularly strong cases for female biology. GHK-Cu's skin and collagen effects are, if anything, more directly relevant for women given the dramatic collagen loss acceleration that accompanies perimenopause. Epithalon's pineal and melatonin regulation is relevant for the sleep disruption that commonly begins in the peri/menopausal transition. TA-1 and its immune effects have no sex-specific contraindications. The main protocol consideration for women is dose — most women run GH secretagogues at the lower end of the dosing range (Ipamorelin 100–200 mcg rather than 300 mcg) and monitor response accordingly. For a safety overview covering general peptide use, see /learn/peptide-safety-guide.

Do I need all of these?

No. The stacks are additive by design — each level adds a new mechanism, not a prerequisite for the previous level to work. The beginner stack (GHK-Cu + Ipamorelin/CJC-1295) is a complete protocol for addressing two of the most universal aging mechanisms. Most people will see meaningful results from just those two. Adding Epithalon and BPC-157 expands the coverage; adding TA-1 and Selank addresses the more specialized mechanisms. Start with what makes sense for your primary concerns, run it long enough to assess honestly (minimum one full 8-12 week cycle), and build from there based on results — not from the most aggressive stack you can construct on paper.

How do I track results?

Baseline testing before you start is the most important step — you can't interpret change without a reference point. Minimum useful baseline markers: IGF-1, CRP (high-sensitivity), fasting insulin, and a basic hormone panel (testosterone/estrogen, DHEA-S, cortisol AM). Photos in consistent lighting every 4 weeks. A brief weekly log of sleep quality, energy, recovery, and joint comfort gives you subjective data that's surprisingly reliable over time. At the 3-month mark, retest your baseline bloodwork and compare. The delta matters more than the absolute values — what moved in the direction you intended is your signal.

New to peptides? Peptide 101: The Beginner's Guide covers everything you need before building any protocol — what peptides are, how they work, reconstitution, storage, and first cycles. Get Peptide 101 — $8.99 →

This article is for informational purposes only and does not constitute medical advice. The peptides discussed are research compounds and are not approved by the FDA for the purposes described. This content is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Always consult a qualified healthcare provider before beginning any peptide protocol, particularly if you have pre-existing health conditions or are taking medications. Individual results will vary.